CYTAX 260MG INJECTION 43.4ML belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It may also be used when other treatments have failed or in combination with other treatments. CYTAX 260MG INJECTION 43.4ML may also be indicated in patients with Kaposi’s sarcoma (cancer that develops from the cells that line lymph or blood vessels) associated with AIDS (Acquired Immuno-Deficiency Syndrome), where other treatments have not been effective. CYTAX 260MG INJECTION 43.4ML contains ‘Paclitaxel’, which works by preventing the growth of certain cancer cells.

FAQs

How does CYTAX 260MG INJECTION 43.4ML work?

CYTAX 260MG INJECTION 43.4ML works by stopping cell division and preventing the growth of certain cancer cells.

Does CYTAX 260MG INJECTION 43.4ML affect fertility?

CYTAX 260MG INJECTION 43.4ML might cause sterility which could be permanent. Please talk to your doctor if you have any concerns.

Does CYTAX 260MG INJECTION 43.4ML cause hair loss?

The most common side effect of CYTAX 260MG INJECTION 43.4ML is hair loss. The hair may grow back after the treatment with CYTAX 260MG INJECTION 43.4ML is finished. However, consult your doctor if you have any concerns.